临床T1-2、N0期腮腺黏液表皮样癌患者的表现与结局:择区性颈清扫和辅助放疗的作用
该研究基于美国国家癌症数据库2004—2016年数据,回顾性分析1233例接受腮腺切除术的成人腮腺黏液表皮样癌(MEC)患者,评估择区性颈清扫(END)与辅助放疗(RT)的作用。结果显示END和RT单独或联合均未改善总生存(校正HR:1.19,95%CI:0.52,2.70,p=0.68)。
要点
- 1233例临床T1-2、N0期腮腺MEC患者中,78.67%接受了END,4.43%出现淋巴结分期上调,0.72%发现包膜外侵犯。
- 67.33%具有晚期病理特征的患者接受了辅助放疗。
- END和RT单独或联合均未观察到总生存获益(校正HR:1.19,95%CI:0.52,2.70,p=0.68)。
核心结论
- 在临床T1-2、N0期腮腺MEC患者中,未观察到END和RT带来生存优势。
研究设计与样本
- 研究为对2004—2016年美国国家癌症数据库的回顾性分析,纳入接受腮腺切除术的成人MEC患者,共1233例。
主要发现
- 组织病理学显示高分化、中分化和低分化MEC分别占47.12%、39.98%和12.90%。
- 78.67%的患者接受了END,其中4.43%出现淋巴结分期上调,0.72%发现包膜外侵犯(ECE)。
- 67.33%具有晚期病理特征的患者接受了RT。
- END和RT单独均未改善总生存(p < 0.05),联合亦未改善总生存(校正HR:1.19,95%CI:0.52,2.70,p = 0.68)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Examine the role of elective neck dissection (END) and adjuvant radiotherapy (RT) in early-stage clinically N0 parotid mucoepidermoid carcinoma (MEC). METHODS: The study is a retrospective analysis of the National Cancer Database, 2004-2016. The study population included adult patients with MEC who underwent parotidectomy. RESULTS: A total of 1233 patients were included. Histopathology demonstrated well, moderately, and poorly differentiated MEC 47.12%, 39.98%, and 12.90% of the time, respectively. END was performed in 78.67% of patients, resulting in nodal upstaging in 4.43% and identification of extracapsular extension (ECE) in 0.72%. RT was utilized in 67.33% of patients with advanced pathological features. Neither END nor RT improved overall survival separately (p < 0.05) or combined (adjusted HR: 1.19, 95%CI: 0.52, 2.70, p = 0.68). CONCLUSION: This study provides an epidemiological perspective regarding patients with clinically T1-2, N0 MEC. There was no observed survival advantage with END and RT.
引用
- Al-Qurayshi Z, Sullivan CB, Allison DB, et al. Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy. Head Neck. 2022. PMID: 35731030. doi:10.1002/hed.27128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。